129432-25-3

Basic information

• Product Name: 2,6-Dichloro-4-methyl-3-aminopyridine
• Synonyms: 2,6-Dichloro-4-methyl-3-amino pyridine;3-Pyridinamine, 2,6-dichloro-4-methyl;2,6-Dichloro-4-methylpyridin-3-amine;2,6-Dichloro-4-Methyl-pyridin-3-ylaMine;2,6-Dichloro-4-methylpyridin-3-amine, 3-Amino-2,6-dichloro-4-picoline
• CAS NO: 129432-25-3
• Molecular Formula: C₆H₆Cl₂N₂
• Molecular Weight: 177.03
• EINECS: 1592732-453-0
• Mol File: 129432-25-3.mol
• Article Data: 7

Chemical Properties

• Melting Point: 83.5-85.5 °C(Solv: benzene (71-43-2))
• Boiling Point: 327.688 °C at 760 mmHg
• Flash Point: 151.981 °C
• Appearance: /
• Density: 1.415 g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.607
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• PKA: 0.06±0.10(Predicted)
• CAS DataBase Reference: 2,6-Dichloro-4-methyl-3-aminopyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 2,6-Dichloro-4-methyl-3-aminopyridine(129432-25-3)
• EPA Substance Registry System: 2,6-Dichloro-4-methyl-3-aminopyridine(129432-25-3)

Safety Data

• Hazardous Substances Data: 129432-25-3(Hazardous Substances Data)

Usage

General Description

2,6-Dichloro-4-methyl-3-aminopyridine, also known as DCMP, is a chemical compound with a molecular formula C6H6Cl2N2. It is a pyridine derivative that is commonly used in the production of pharmaceuticals and agrochemicals. DCMP is a white to off-white crystalline powder that is sparingly soluble in water. It is a highly reactive compound and is often used as a reagent in organic synthesis. DCMP has several industrial applications, including as an intermediate in the synthesis of pharmaceuticals and as a catalyst in organic reactions. It is important to handle DCMP with caution as it is considered to be a hazardous substance.

InChI:InChI=1/C6H6Cl2N2/c1-3-2-4(7)10-6(8)5(3)9/h2H,9H2,1H3

Upstream product

• 5444-02-0 2,6-dihydroxy-3-cyano-4-methylpyrimidine 
• 875-35-4 2,6-dichloro-4-methylnicotinonitrile 
• 38841-54-2 2,6-dichloro-4-methyl-3-pyridinecarboxamide 

Downstream Products

• 3430-27-1 3-amino-4-methylpyridine 

Relevant articles and documents

Synthesis of nevirapine and its major metabolite

Several synthetic methods were developed during the process optimization for the large scale synthesis of nevirapine (1), a non-nucleoside inhibitor of HIV-1 Reverse Transcriptase. The synthesis of its putative major metabolite 11-cyclopropyl-5,11-dihydro-4-hydroxymethyl-6H-[3,2-b:2',3'-e][1,4]dia zepin-6-one (2) and the oxidation of 2 to the corresponding aldehyde 3, are described.

COMPOUNDS FOR TREATING HUNTINGTON'S DISEASE

The present description relates to compounds, forms, and pharmaceutical compositions thereof and methods of using such compounds, forms, or compositions thereof for treating or ameliorating Huntington's disease. In particular, the present description relates to substituted bicyclic heteroaryl compounds of Formula (I), forms and pharmaceutical compositions thereof and methods of using such compounds, forms, or compositions thereof for treating or ameliorating Huntington's disease.

Method for the preparation of 5,11-dihydro-6h-dipyrido [3,2-b:2',3'-e][1,4]diazepines

This invention relates to a novel method for preparing certain dipyrido-diazepines.